Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Financial Flexibility Index
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Financial Flexibility Index of 0.34x as of September 2025. Free cash flow of CN¥692.94 Million (operating CF CN¥400.70 Million minus capex CN¥292.24 Million) represents 0% of total liabilities (CN¥2.05 Billion). Also explore 002294 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shenzhen Salubris Pharmaceuticals Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Check 002294 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Shenzhen Salubris Pharmaceuticals Co Ltd. For the full company profile including market capitalisation, see market cap of Shenzhen Salubris Pharmaceuticals Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | CN¥1.81 Billion | CN¥1.19 Billion | CN¥1.71 Billion | ▼ -8.0% |
| 2023 | 1.15x | CN¥1.54 Billion | CN¥869.79 Million | CN¥1.34 Billion | ▲ +30.2% |
| 2022 | 0.88x | CN¥1.57 Billion | CN¥970.80 Million | CN¥1.78 Billion | ▼ -36.6% |
| 2021 | 1.39x | CN¥1.67 Billion | CN¥1.18 Billion | CN¥1.20 Billion | ▼ -8.4% |
| 2020 | 1.52x | CN¥2.02 Billion | CN¥1.37 Billion | CN¥1.33 Billion | ▼ -17.4% |
| 2019 | 1.84x | CN¥1.96 Billion | CN¥1.51 Billion | CN¥1.07 Billion | ▲ +13.7% |
| 2018 | 1.62x | CN¥1.67 Billion | CN¥1.34 Billion | CN¥1.03 Billion | ▼ -36.1% |
| 2017 | 2.54x | CN¥1.79 Billion | CN¥1.46 Billion | CN¥705.86 Million | ▲ +62.1% |
| 2016 | 1.56x | CN¥1.68 Billion | CN¥1.43 Billion | CN¥1.07 Billion | ▼ -16.3% |
| 2015 | 1.87x | CN¥1.29 Billion | CN¥1.06 Billion | CN¥691.25 Million | ▲ +30.8% |
| 2014 | 1.43x | CN¥1.18 Billion | CN¥982.25 Million | CN¥827.95 Million | ▼ -33.7% |
| 2013 | 2.16x | CN¥1.10 Billion | CN¥668.52 Million | CN¥508.36 Million | ▼ -0.2% |
| 2012 | 2.16x | CN¥807.96 Million | CN¥521.21 Million | CN¥374.02 Million | ▲ +27.8% |
| 2011 | 1.69x | CN¥524.92 Million | CN¥272.32 Million | CN¥310.52 Million | ▲ +27.6% |
| 2010 | 1.33x | CN¥410.13 Million | CN¥186.65 Million | CN¥309.50 Million | ▼ -27.1% |
| 2009 | 1.82x | CN¥269.96 Million | CN¥134.28 Million | CN¥148.59 Million | ▲ +89.9% |
| 2008 | 0.96x | CN¥139.37 Million | CN¥77.89 Million | CN¥145.70 Million | ▲ +58.3% |
| 2007 | 0.60x | CN¥66.46 Million | CN¥52.75 Million | CN¥109.98 Million | ▲ +45.3% |
| 2006 | 0.42x | CN¥21.71 Million | CN¥12.00 Million | CN¥52.19 Million | — |